At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HIMS Hims & Hers Health Inc.
Trading 04-09 12:32:40 EDT
19.39
+0.00
-0.03%
High19.60Low18.96Vol6.78M
Open19.31D1 Closing19.39Amplitude3.30%
Mkt Cap4.41BTradable Cap3.83BTotal Shares227.65M
T/O130.54MT/O Rate3.43%Tradable Shares197.51M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Hims & Hers’ Shift to Branded Obesity Drugs Pressures Stock — Will the Bet Pay Off?
TIPRANKS  ·  04-09 19:51
Hims & Hers’ Shift to Branded Obesity Drugs Pressures Stock — Will the Bet Pay Off?
Hims & Hers Health's Shift to Branded GLP-1s to Weigh on Margins, BofA Securities Says
MT Newswires Live  ·  04-08 23:30
Hims & Hers Health's Shift to Branded GLP-1s to Weigh on Margins, BofA Securities Says
BUZZ-BofA cuts PT on Hims & Hers, cites near-term pressure from branded GLP-1 shift
Reuters  ·  04-08 22:30
BUZZ-BofA cuts PT on Hims & Hers, cites near-term pressure from branded GLP-1 shift
BofA Securities Adjusts Price Target on Hims & Hers Health to $21 From $23, Maintains Neutral Rating
MT Newswires Live  ·  04-08 22:27
BofA Securities Adjusts Price Target on Hims & Hers Health to $21 From $23, Maintains Neutral Rating
Hims & Hers Health (HIMS) Is Down 6.1% After Expanding GLP-1 Access With Novo Nordisk Collaboration
Simply Wall St.  ·  04-08 20:28
Hims & Hers Health (HIMS) Is Down 6.1% After Expanding GLP-1 Access With Novo Nordisk Collaboration
New Derivative Income ETFs Aren't Worth the Risks -- Barrons.com
Dow Jones  ·  04-08 14:00
New Derivative Income ETFs Aren't Worth the Risks -- Barrons.com
Hims & Hers CFO Oluyemi Okupe disposes of common shares worth $79,410
Reuters  ·  04-08 05:15
Hims & Hers CFO Oluyemi Okupe disposes of common shares worth $79,410
Mixed options sentiment in Hims and Hers Health with shares down 4.55%
TIPRANKS  ·  04-08 02:50
Mixed options sentiment in Hims and Hers Health with shares down 4.55%
Analysts’ Top Healthcare Picks: AbbVie (ABBV), Takeda Pharmaceutical Co (TKPHF)
TIPRANKS  ·  04-06
Analysts’ Top Healthcare Picks: AbbVie (ABBV), Takeda Pharmaceutical Co (TKPHF)
Hims & Hers Health: Customer Medical Records Were Not Impacted by This Incident, Neither Were Communications With Health Care Providers on Platform
THOMSON REUTERS  ·  04-03
Hims & Hers Health: Customer Medical Records Were Not Impacted by This Incident, Neither Were Communications With Health Care Providers on Platform
Hims & Hers Health Inc: on Mar 3, Identified Personal Information Related to Limited Set of Individuals Present in Affected Service Tickets
THOMSON REUTERS  ·  04-03
Hims & Hers Health Inc: on Mar 3, Identified Personal Information Related to Limited Set of Individuals Present in Affected Service Tickets
Hims & Hers Health: in Response, Co Undertook a Review of Affected Service Tickets to Determine What Information Was Present & to Whom It Relates
THOMSON REUTERS  ·  04-03
Hims & Hers Health: in Response, Co Undertook a Review of Affected Service Tickets to Determine What Information Was Present & to Whom It Relates
Hims & Hers Health Inc: Offering Complimentary Credit Monitoring & Identity Restoration Services for 12 Months Through Cyberscout
THOMSON REUTERS  ·  04-03
Hims & Hers Health Inc: Offering Complimentary Credit Monitoring & Identity Restoration Services for 12 Months Through Cyberscout
Hims & Hers Health: on Feb 5, Became Aware of Suspicious Activity Affecting Our Third-Party Customer Service Platform
THOMSON REUTERS  ·  04-03
Hims & Hers Health: on Feb 5, Became Aware of Suspicious Activity Affecting Our Third-Party Customer Service Platform
BRIEF-Telehealth Giant Hims & Hers Says Its Customer Support System Was Hacked - TechCrunch
Reuters  ·  04-03
BRIEF-Telehealth Giant Hims & Hers Says Its Customer Support System Was Hacked - TechCrunch
US FDA clarifies policies on compounding of GLP-1 medicines
Reuters  ·  04-02
US FDA clarifies policies on compounding of GLP-1 medicines
Option traders moderately bearish in Hims and Hers Health with shares down 3.43%
TIPRANKS  ·  03-31
Option traders moderately bearish in Hims and Hers Health with shares down 3.43%
Hims & Hers Health Is Maintained at Hold by TD Cowen
Dow Jones  ·  03-27
Hims & Hers Health Is Maintained at Hold by TD Cowen
Buy Rating on Hims & Hers: Undervalued Growth Leveraging Novo Nordisk GLP-1 Partnership and Scale Advantages
TIPRANKS  ·  03-27
Buy Rating on Hims & Hers: Undervalued Growth Leveraging Novo Nordisk GLP-1 Partnership and Scale Advantages
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Meiragtx Holdings (MGTX), Hims & Hers Health (HIMS) and Siemens Healthineers AG (OtherSEMHF)
TIPRANKS  ·  03-27
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Meiragtx Holdings (MGTX), Hims & Hers Health (HIMS) and Siemens Healthineers AG (OtherSEMHF)

Introduction

Company Name.
Hims & Hers Health Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Issue price:
--